An update of cyclic nucleotide phosphodiesterase as a target for cardiac diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An update of cyclic nucleotide phosphodiesterase as a target for cardiac diseases

Published:2020-09-21 Issue:2 Volume:16 Page:183-196
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Chen Si¹²,Yan Chen¹

Affiliation:

1. Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

2. Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2020.1821643

Reference151 articles.

1. Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use

2. Cyclic AMP synthesis and hydrolysis in the normal and failing heart

3. Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts

4. What Is the Role of β-Adrenergic Signaling in Heart Failure?

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Les phosphodiestérases des nucléotides cycliques;médecine/sciences;2024-06

2. Phosphodiesterase 1A physically interacts with YTHDF2 and reinforces the progression of non-small cell lung cancer;2024-05-23

3. Discovery of 3-trifluoromethyl-substituted pyrazoles as selective phosphodiesterase 10A inhibitors for orally attenuating isoprenaline-induced cardiac hypertrophy;Chinese Chemical Letters;2024-05

4. Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension;Acta Pharmaceutica Sinica B;2024-04

5. Phosphodiesterases in heart and vessels- From Physiology to Diseases;Physiological Reviews;2023-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3